학술논문
Phase 1/2 Study of Treatment Response With VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor, in Patients with Thyroid Eye Disease (TED)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15525783